Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Apple
AAPL
US Stock MarketDetailed Quotes
MTNB Matinas BioPharma
- 0.6210
- -0.0230-3.57%
Trading Apr 30 12:46 ET
3.16MMarket Cap-0.12P/E (TTM)
0.6435High0.6110Low18.44KVolume0.6435Open0.6440Pre Close11.54KTurnover0.39%Turnover RatioLossP/E (Static)5.09MShares9.600052wk High0.42P/B2.93MFloat Cap0.474852wk Low--Dividend TTM4.71MShs Float197.5000Historical High--Div YieldTTM5.05%Amplitude0.4748Historical Low0.6260Avg Price1Lot Size
Matinas BioPharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -3.97%-15.89M | 23.35%-3.51M | 20.80%-3.5M | -41.63%-3.11M | -41.15%-5.77M | 20.24%-15.28M | -6.51%-4.58M | 11.09%-4.42M | 57.26%-2.19M | 14.07%-4.09M |
| Net income from continuing operations | -5.71%-24.25M | -58.69%-8.43M | 29.40%-4.28M | 5.63%-5.72M | -5.64%-5.82M | -9.26%-22.94M | -46.23%-5.31M | -10.86%-6.06M | -2.31%-6.06M | 7.78%-5.51M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | -50.00%1K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 3.29%972K | 2.92%247K | 2.52%244K | 2.99%241K | 4.80%240K | 4.79%941K | 6.19%240K | 3.48%238K | 1.30%234K | 8.53%229K |
| Deferred tax | ---84K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non cash items | -115.89%-17K | -105.88%-1K | -82.35%3K | -227.59%-37K | -59.09%18K | -78.69%107K | -67.92%17K | -64.58%17K | -40.82%29K | -87.50%44K |
| Change In working capital | -107.86%-131K | 110.82%86K | -336.22%-437K | -40.82%1.42M | -906.72%-1.2M | 134.81%1.67M | 65.22%-795K | 115.43%185K | 440.83%2.4M | 80.20%-119K |
| -Change in prepaid assets | -85.26%587K | -1,838.46%-252K | 108.74%25K | -35.18%1.21M | -116.24%-393K | 194.90%3.98M | 99.15%-13K | 54.31%-286K | 185.73%1.86M | 1,883.61%2.42M |
| -Change in payables and accrued expense | 96.41%-63K | 181.14%512K | -147.56%-293K | -44.76%369K | 72.95%-651K | -2,336.11%-1.75M | 0.79%-631K | 240.64%616K | -58.20%668K | -303.86%-2.41M |
| -Change in other current liabilities | -16.55%-655K | -15.23%-174K | -16.55%-169K | -17.91%-158K | -16.67%-154K | -8.08%-562K | -17.05%-151K | -7.41%-145K | -3.88%-134K | -3.94%-132K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -3.97%-15.89M | 23.35%-3.51M | 20.80%-3.5M | -41.63%-3.11M | -41.15%-5.77M | 20.24%-15.28M | -6.51%-4.58M | 11.09%-4.42M | 57.26%-2.19M | 14.07%-4.09M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -30.46%9.21M | -83.11%500K | 789.85%9.65M | -147.40%-2.94M | -33.33%2M | 171.52%13.24M | 7,147.62%2.96M | -81.15%1.08M | 263.45%6.2M | 1.32%3M |
| Net PPE purchase and sale | --0 | --0 | --0 | ---- | ---- | 75.56%-218K | --0 | 93.60%-16K | ---- | ---- |
| Net investment purchase and sale | -31.59%9.21M | -83.11%500K | 776.91%9.65M | -145.91%-2.94M | -33.33%2M | 133.32%13.46M | --2.96M | -81.67%1.1M | 271.26%6.4M | -14.43%3M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -30.46%9.21M | -83.11%500K | 789.85%9.65M | -147.40%-2.94M | -33.33%2M | 171.52%13.24M | 7,147.62%2.96M | -81.15%1.08M | 263.45%6.2M | 1.32%3M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 131,157.14%9.17M | 0.00%-1K | -6,600.00%-67K | 919,000.00%9.19M | 1,425.00%53K | -108.86%-7K | 80.00%-1K | 66.67%-1K | 83.33%-1K | -104.30%-4K |
| Net issuance payments of debt | 28.57%-5K | 0.00%-1K | -100.00%-2K | 0.00%-1K | 75.00%-1K | 65.00%-7K | 80.00%-1K | 66.67%-1K | 83.33%-1K | 33.33%-4K |
| Net common stock issuance | --9.18M | --0 | ---65K | --9.19M | --54K | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 131,157.14%9.17M | 0.00%-1K | -6,600.00%-67K | 919,000.00%9.19M | 1,425.00%53K | -108.86%-7K | 80.00%-1K | 66.67%-1K | 83.33%-1K | -104.30%-4K |
| Net cash flow | ||||||||||
| Beginning cash position | -28.86%5.04M | 58.40%10.55M | -55.31%4.47M | -77.94%1.32M | -28.86%5.04M | -66.73%7.08M | -41.74%6.66M | -6.16%9.99M | -69.41%5.99M | -66.73%7.08M |
| Current changes in cash | 222.22%2.5M | -85.86%-3.01M | 282.22%6.08M | -21.45%3.15M | -240.60%-3.72M | 85.61%-2.04M | 62.72%-1.62M | -529.34%-3.34M | 144.84%4M | 35.90%-1.09M |
| End cash Position | 49.57%7.53M | 49.57%7.53M | 58.40%10.55M | -55.31%4.47M | -77.94%1.32M | -28.86%5.04M | -28.86%5.04M | -41.74%6.66M | -6.16%9.99M | -69.41%5.99M |
| Free cash flow | -2.51%-15.89M | 23.35%-3.51M | 21.08%-3.5M | -29.69%-3.11M | -41.15%-5.77M | 22.71%-15.5M | -5.48%-4.58M | 15.04%-4.44M | 53.82%-2.4M | 22.90%-4.09M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
